Heart news and heart widget

ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced completion of the final feasibility milestone in the development of the ATS Forcefield(TM) technology. The animal feasibility study has been completed with positive results regarding the inhibition of platelet adhesion on mechanical heart valve prostheses.

Broken hearts could one day be mended using a novel scaffold developed by MIT researchers and colleagues. The idea is that living heart cells or stem cells seeded onto such a scaffold would develop into a patch of cardiac tissue that could be used to treat congenital heart defects, or aid the recovery of tissue damaged by a heart attack. The biodegradable scaffold would be gradually absorbed into the body, leaving behind new tissue.

Broken hearts could one day be mended using a novel scaffold developed by MIT researchers and colleagues. The idea is that living heart cells or stem cells seeded onto such a scaffold would develop into a patch of cardiac tissue that could be used to treat congenital heart defects, or aid the recovery of tissue damaged by a heart attack. The biodegradable scaffold would be gradually absorbed into the body, leaving behind new tissue.

Title: Study Sheds Light on Painkillers' Heart RiskCategory: health newscreated: 11/4/2008 2:00:00 amlast Editorial review: 11/4/2008

HealthDay - TUESDAY, Nov. 4 (HealthDay News) -- The risk of sudden death after a heart attack has improved significantly over the past three decades, but the first 30 days remain a period of great danger, an historical study shows.

HealthDay - TUESDAY, Nov. 4 (HealthDay News) -- Post-traumatic stress disorder (PTSD) linked to a heart attack can raise the long term risk of death for people with implanted cardiac defibrillators, a new study suggests.